Press-reliz Rivaroksaban v doze 10 mg 1 raz v sutki odobren Evropeyskoy komissiey i Upravleniem po kontrolyu kachestva pishchevykh produktov i lekarstvennykh sredstv SShA dlya dlitel'noy profilaktiki retsidivov venoznykh
- Authors: - -
- Issue: Vol 20, No 1 (2018)
- Pages: 88-89
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95047
- ID: 95047
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##References
- Weitz J.I, Lensing A.W.A, Prins M.H. et al. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Eng J Med 2017.
- Kearon C, Akl E.A, Omelas J et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149: 315-52.
